Cargando…

Long-term survival with targeted therapy in an advanced non-small cell lung cancer patient based on genetic profiling

Non-small cell lung cancer (NSCLC) is a profoundly devastating disease that is the leading cause of cancer-related death worldwide. With the rapid development of next-generation sequencing (NGS), which has supplied the ability to decode tumors at the DNA level, so that targeted therapy plays a cruci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Fang-Fang, Guo, Wei, Tian, Rui-Fen, Guo, Yi, Yang, Yan-Li, Song, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225131/ https://www.ncbi.nlm.nih.gov/pubmed/32420078 http://dx.doi.org/10.21037/tlcr.2020.01.21

Ejemplares similares

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
por: Guo, Long-Hua, et al.
Publicado: (2020)

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
por: Li, Xiaofen, et al.
Publicado: (2018)

Long‐term survival in locally advanced non‐small cell lung cancer invading the great vessels and heart
por: Park, Byungjoon, et al.
Publicado: (2018)

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
por: Shen, Fangfang, et al.
Publicado: (2023)

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Frigola, Joan, et al.
Publicado: (2021)

Retrospective analysis of long‐term survival factors in patients with advanced non‐small cell lung cancer treated with nivolumab
por: Murakami, Yusuke, et al.
Publicado: (2022)

Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
por: Wang, Fang, et al.
Publicado: (2019)

Long term survival of small cell lung cancer patients after chemotherapy.
por: van der Gaast, A., et al.
Publicado: (1993)

What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
por: Zhang, Xue, et al.
Publicado: (2022)

Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
por: Wang, Cong, et al.
Publicado: (2018)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022)

Long-term results of postoperative unsuspected small cell lung cancer on real-world data
por: Guo, Juntang, et al.
Publicado: (2022)

Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy
por: Zhang, Qun, et al.
Publicado: (2019)

Comparison of Long-term Survival of Patients With Early-Stage Non–Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy
por: Chi, Alexander, et al.
Publicado: (2019)

Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report
por: Chen, Hui Jun, et al.
Publicado: (2021)

Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan
por: Chiang, Tai-An, et al.
Publicado: (2008)

Pemetrexed long-term maintenance therapy for advanced severe lung cancer with long-term progression-free survival: a case report
por: Zhao, Weichao, et al.
Publicado: (2023)

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis
por: Wang, Jian-Zhong, et al.
Publicado: (2017)

Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study
por: Xing, Puyuan, et al.
Publicado: (2019)

Pembrolizumab provides long‐term survival benefits in advanced non‐small cell lung cancer: The 5‐year outcomes of the KEYNOTE‐024 trial
por: Li, Fengtan, et al.
Publicado: (2021)

CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment
por: Chen, Nai-Bin, et al.
Publicado: (2022)

Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma
por: Song, Yueqiang, et al.
Publicado: (2019)

Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy
por: Pu, Xia, et al.
Publicado: (2014)

Long Term Survival of Patients with Unsuspected N2 Disease in Non-Small Cell Lung Cancer
por: Lee, Deok Heon, et al.
Publicado: (2013)

Long-Term Survival of Patients with Metastatic Non-Small-Cell Lung Cancer over Five Decades
por: Bar, Jair, et al.
Publicado: (2021)

Dynamic nomogram for long-term survival in patients with non-small cell lung cancer after pneumonectomy
por: Wang, Zi-Ming, et al.
Publicado: (2021)

Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy
por: Möller, Miriam, et al.
Publicado: (2023)

Novel approaches for long-term lung transplant survival
por: Miller, Cynthia L., et al.
Publicado: (2022)

The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching
por: Xu, Li-Li, et al.
Publicado: (2021)

Long‐term survival analysis of patients with stage IIIB‐IV non‐small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis
por: Li, Xuejiao, et al.
Publicado: (2022)

Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer
por: Wang, Fang, et al.
Publicado: (2012)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

Cancer Targeted Gene Therapy of BikDD Inhibits Orthotopic Lung Cancer Growth and Improves Long-term Survival
por: Sher, Yuh-Pyng, et al.
Publicado: (2009)

Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database
por: Lin, Shao-Feng, et al.
Publicado: (2020)

Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer
por: Moreno-Rubio, Juan, et al.
Publicado: (2020)

Impact of Combination Epidural and General Anesthesia on the Long-Term Survival of Gastric Cancer Patients: A Retrospective Study
por: Wang, Jiangling, et al.
Publicado: (2016)

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
por: Molinier, O., et al.
Publicado: (2021)

Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer
por: Jiang, Wensheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_32msi5ddmdhdblk0k8cmjt9fs4